-
平臺編號：bio-48052
-
國際編號：ATCC 30882
-
拉丁屬名： Leishmania major
-
規(guī)格：frozen
-
用途：ATCC原裝進口
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Leishmania major
ATCC? Number:30882?
Organism: Leishmania major (Yakimoff and Schokhor) Bray et al.
Designations: Jericho II [WR 061c]
Isolation: reisolated from patient with a vaccinated inoculation of LRC-L136 (Jericho), Israel, Occupied Territory, 1967
Depositors: WRAIR
History: ATCC<<--WRAIR<<--B. Walton <<--- Z. Greenberg strain LRC-L137
Biosafety Level:2
Shipped: frozen
Growth Conditions: ATCCmedium 807: Brain heart infusion blood agarTemperature: 25.0°C Duration: axenic Protocol: ATCCNO: 11745 SPEC: See general instructions for thawing and storage of frozen material before proceeding. Add thawed contents to a single 16 x 125 mm glass screw-capped test tube of the appropriate medium. Incubate the culture vertically with the cap screwed on tightly. It is essential to establish cultures initially in small volumes. Once established, the culture can be scaled up to larger volumes. Vigorously agitate the culture and aseptically transfer 0.1 ml of culture to a fresh tube of medium weekly.
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Applications: used to vaccinate against L. tropica [57555]
Comments: Promastigotes.
References: 57555: Naggan L, et al. Follow-up study of a vaccination programme against cutaneous leishmaniasis. II. Vaccination with a recently isolated strain of L. tropica from Jericho. Trans. R. Soc. Trop. Med. Hyg. 66: 239-243, 1972. PubMed: 5048790
ATCC30882
Organism: Leishmania major (Yakimoff and Schokhor) Bray et al.
Designations: Jericho II [WR 061c]
Isolation: reisolated from patient with a vaccinated inoculation of LRC-L136 (Jericho), Israel, Occupied Territory, 1967
Depositors: WRAIR
History: ATCC<<--WRAIR<<--B. Walton <<--- Z. Greenberg strain LRC-L137
Biosafety Level:2
Shipped: frozen
Growth Conditions: ATCCmedium 807: Brain heart infusion blood agarTemperature: 25.0°C Duration: axenic Protocol: ATCCNO: 11745 SPEC: See general instructions for thawing and storage of frozen material before proceeding. Add thawed contents to a single 16 x 125 mm glass screw-capped test tube of the appropriate medium. Incubate the culture vertically with the cap screwed on tightly. It is essential to establish cultures initially in small volumes. Once established, the culture can be scaled up to larger volumes. Vigorously agitate the culture and aseptically transfer 0.1 ml of culture to a fresh tube of medium weekly.
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Applications: used to vaccinate against L. tropica [57555]
Comments: Promastigotes.
References: 57555: Naggan L, et al. Follow-up study of a vaccination programme against cutaneous leishmaniasis. II. Vaccination with a recently isolated strain of L. tropica from Jericho. Trans. R. Soc. Trop. Med. Hyg. 66: 239-243, 1972. PubMed: 5048790
ATCC30882
